HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024.  The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306. The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for the continued listing on The Nasdaq Capital Market. The reverse split was authorized by the Company's shareholders on June 17, 2024, granting the Company's Board of Directors (the "Board") the discretion to determine the timing and ratio of the split within a range of 1-2 and 1-16. The Board has now decided on the 1-for-10 ratio and will amend the Company's Amended and Restated Certificate of Incorporation to reflect this change. This reverse stock split is in addition to the Company's previous 1 for 15 reverse stock split which was effective April 10, 2024. As a result of the reverse stock split, every ten shares of the Company's common stock issued and outstanding prior to the opening of trading on July 3, 2024 will be consolidated into one issued and outstanding share, with no change in the nominal par value per share of $0.001.  No fractional shares will be issued as a result of ...